Compugroup Medical : Upcoming changes to the CGM Management Board

Koblenz, April 15th, 2019. CompuGroup Medical SE (CGM) today announced that Chris-tian Teig will be departing from his position as Chief Financial Officer effective July 31st, 2019. CGM has appointed Michael Rauch who will take over as new CFO from August 1st, 2019. Christian Teig will remain for some time at CGM to ensure a smooth transition.

Klaus Esser, Chairman of the Supervisory Board, said: 'Since 2008, Christian has played a key role in our executive leadership team and made a big contribution to the success of CGM. During his tenure, we have expanded our geographic and healthcare sector foot-print, quadrupled in size and increased our value tenfold. On behalf of the Supervisory Board, I would like to thank Christian for his outstanding commitment over more than a decade and wish him every success in the future.'

Frank Gotthardt, Chief Executive Officer, said: 'A wholehearted thank you to Christian also from my side. He has played a very important part in the development of CGM since our IPO and ensured financial strength and investor support, which has contribut-ed to our double-digit growth and exceptional market position. CGM is perfectly posi-tioned to seize the great opportunities of the sustainably growing eHealth business in 2019 and in many exciting years to come.'

Significant value creation for customers, employees and shareholders

Christian B. Teig, Chief Financial Officer, said: 'I have been with CGM for almost eleven years and it has been a privilege to be a member of this management board. The com-pany is at an all-time high in financial and operational strength and in a leading position to benefit from the continued digitization of the world's healthcare systems. I am confi-dent that CGM will continue to create significant value for customers, employees and shareholders'.

The new CFO Michael Rauch comes from the same position in Douglas GmbH, a leading Beauty retailer in Europe with sales of 3.3 billion euro in 21 European countries. During his CFO time Douglas has added more than 500 million euro of sales supported by vari-ous acquisitions and has increased operational results by a double-digit percentage. Prior to Douglas he had been working for many years at Henkel, including CFO of Henkel Adhesive and CFO of Henkel Beauty Care division. He has over 20 years of international management experience in finance, having also worked in the U.K., Sweden and China.

A remarkable success story

Michael Rauch, incoming CFO, said: 'I look forward to joining a value-driven, experi-enced leadership team with a clear dedication towards long-term profitable growth and strong cash flow orientation building on a remarkable track record.'

'Michael is a highly qualified CFO with all the right credentials to support CGM's growth trajectory, both organically and by acquisitions. I look forward to the continued support of a strong CFO and the contributions Michael will make to our exciting growth strategy. Together, we will further develop CGM, shape the future and manifest our position as a global leader in healthcare IT.', Gotthardt concludes.